Your browser doesn't support javascript.
High-dose budesonide for early COVID-19 - Authors' reply.
Hobbs, F D Richard; Yu, Ly-Mee; Saville, Benjamin R; Bafadhel, Mona; Butler, Christopher C.
  • Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: richard.hobbs@phc.ox.ac.uk.
  • Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Saville BR; Berry Consultants, Austin, TX, USA.
  • Bafadhel M; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX2 6GG, UK.
  • Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
Lancet ; 398(10317): 2147-2148, 2021 12 11.
Article in English | MEDLINE | ID: covidwho-1561258

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Asthmatic Agents / COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Asthmatic Agents / COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article